Fresenius Medical Care AG & Co. KGAA

(NYSE:FMS)

View:
Quarterly Data
Annual Data
Note: All numbers in thousands

	Sep 30, 2008	Jun 30, 2008	Mar 31, 2008	Dec 31, 2007
Operating revenue
Total Revenue	2,713,265	2,665,296	2,511,724	2,569,288
Operating Revenue	2,713,265	2,665,296	2,511,724	2,569,288
Adjustments To Revenue	—	—	—	—
Cost Of Sales	1,695,989	1,639,172	1,559,799	1,569,703
Cost Of Sales With Depreciation	1,803,886	1,741,410	1,656,425	1,673,172
Gross Operating Profit	1,017,276	1,026,124	951,925	999,585
Operating Expenses
Research And Development Expenses	20,206	20,654	19,118	22,977
Selling General And Administrative Expenses	466,983	474,187	447,510	445,469
Advertising Expenses	—	—	—	—
Operating Income Before Depreciation	530,087	531,283	485,297	531,139
Operating Income	422,190	429,045	388,671	427,670
Depreciation	107,897	102,238	96,626	103,469
Depreciation Unreconciled	—	—	—	—
Amortization	—	—	—	—
Amortization Of Intangibles	—	—	—	—
Operating Income After Depreciation	422,190	429,045	388,671	427,670
Non Operating Expenses
Interest Expense	93,516	89,561	88,198	99,268
Pre Tax Income	335,141	346,903	305,853	337,942
Income Taxes	122,534	128,990	114,097	134,555
Minority Interest	6,272	6,825	5,883	5,973
Income Before Income Taxes	335,141	346,903	305,853	337,942
Net Income From Continuing Operations	206,335	211,088	185,873	197,414
Net Income From Discontinued Operations	—	—	—	—
Net Income From Total Operations	206,335	211,088	185,873	197,414
Non Recurring Events
Extraordinary Income Losses	—	—	—	—
Income From Cummulated Effect Of Accounting Changes	—	—	—	—
Income From Tax Loss Carryforward	—	—	—	—
Other Gains And Losses	—	—	—	—
Total Net Income	206,335	211,088	185,873	197,414
Normalized Income	206,335	211,088	185,873	197,414
NetIncome Available For Common	206,335	211,088	185,873	197,414
Preferred Dividends	—	—	—	—
Excise Taxes	—	—	—	—

	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004
Operating revenue
Total Revenue	9,720,314	8,499,038	6,771,819	6,228,002
Operating Revenue	9,720,314	8,499,038	6,771,819	6,228,002
Adjustments To Revenue	—	—	—	—
Cost Of Sales	6,001,189	5,312,784	4,187,702	3,909,532
Cost Of Sales With Depreciation	6,364,519	5,621,482	4,439,154	4,142,117
Gross Operating Profit	3,719,125	3,186,254	2,584,117	2,318,470
Operating Expenses
Research And Development Expenses	66,523	51,293	50,955	51,364
Selling General And Administrative Expenses	1,709,150	1,548,369	1,342,792	1,182,176
Advertising Expenses	—	—	—	—
Operating Income Before Depreciation	1,943,452	1,586,592	1,190,370	1,084,930
Operating Income	1,580,122	1,318,127	938,918	852,345
Depreciation	363,330	308,698	251,452	232,585
Depreciation Unreconciled	—	—	—	—
Amortization	—	—	—	—
Amortization Of Intangibles	—	—	—	—
Operating Income After Depreciation	1,580,122	1,277,894	938,918	852,345
Non Operating Expenses
Interest Expense	399,635	371,678	191,379	197,164
Pre Tax Income	1,209,075	966,881	765,726	668,599
Income Taxes	465,652	413,489	308,748	265,415
Minority Interest	26,293	16,646	2,026	1,186
Income Before Income Taxes	1,209,075	966,881	765,726	668,599
Net Income From Continuing Operations	717,130	536,746	454,952	401,998
Net Income From Discontinued Operations	—	—	—	—
Net Income From Total Operations	717,130	536,746	454,952	401,998
Non Recurring Events
Extraordinary Income Losses	—	—	—	—
Income From Cummulated Effect Of Accounting Changes	—	—	—	—
Income From Tax Loss Carryforward	—	—	—	—
Other Gains And Losses	—	—	—	—
Total Net Income	717,130	536,746	454,952	401,998
Normalized Income	717,130	536,746	454,952	401,998
NetIncome Available For Common	717,130	536,746	454,952	401,998
Preferred Dividends	—	—	—	—
Excise Taxes	—	—	—	—